StapleCat/Inveniam Group

Overview

StapleCat/Inveniam Group is a network of private investors and investment firms based in Barcelona, Spain, dedicated to supporting innovative startups across various sectors, including biotechnology. The group specializes in technology transfer, corporate finance, and strategic advisory services, focusing on technology-based transactions in life sciences and resource sustainability. They offer a unique combination of skills and industry insight to assist institutions, investors, startups, and corporations with specialized advisory services. Operating in Spain, Belgium, Israel, and Mexico, StapleCat/Inveniam Group has a diversified team with expertise across different sectors. They have been instrumental in raising over €120 million in public funding between 2019 and 2023, demonstrating a strong track record in securing financial support for their clients. Their success rate in Horizon Europe EIC projects stands at 38%, and they have a 53% success rate in Horizon Europe Societal Challenges. The group's portfolio includes various projects in the life sciences and sustainability sectors, such as the FENIX Project Consortium, MIMARK, NIMBLE Diagnostics, Innitius, Gate2Brain, and SafeWax Consortium. These initiatives highlight their commitment to advancing innovative solutions in critical areas. Their approach combines financial advisory, strategic consulting, and public funding access services to guide startups and institutions through the complexities of bringing innovative products to market.